Applied Genetic Technologies reported $0 in Sales Revenues for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Alimera Sciences ALIM:US $ 11.9M 2.06M
Applied Genetic Technologies AGTC:US $ 0M 0M
Biogen BIIB:US $ 2531.8M 202M
Bluebird Bio BLUE:US $ 1.94M 0.34M
Celldex Therapeutics CLDX:US $ 0.17M 0.16M
Gilead Sciences GILD:US $ 6590M 654M
Insmed INSM:US $ 53.11M 3.02M
Intercept Pharmaceuticals ICPT:US $ 88.58M 3.82M
Regeneron Pharmaceuticals REGN:US $ 2965.1M 1986.6M
Rigel Pharmaceuticals RIGL:US $ 16.74M 3.67M
Roche Holding ROG:VX 16.44B 474M
Ultragenyx Pharmaceutical RARE:US $ 79.94M 3.45M